Prostate Cancer‐Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
Ong SY, Taverna J, Jokerst C, Enzler T, Hammode E, Rogowitz E, Green MR, Babiker HM. Prostate Cancer‐Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix. Case Reports In Oncological Medicine 2015, 2015: 212543. PMID: 26613055, PMCID: PMC4646996, DOI: 10.1155/2015/212543.Peer-Reviewed Original ResearchDisseminated intravascular coagulationProstate cancerIntravascular coagulationExcessive fibrinolysisGonadotropin-releasing hormone receptor antagonistTherapeutic drug optionsHormone receptor antagonistLife-threatening variantDays of treatmentHemorrhagic complicationsSystemic bleedingDrug optionsReceptor antagonistPatient's coagulopathySingle injectionCoagulopathyDegarelixPatientsFibrinolysisCancerCoagulationBleedingComplicationsAntagonistHypofibrinogenemia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply